Scholars Central

Case reportPublished 26 Jul 2017

Response of Refractory New Daily Persistent Headache to Intravenous Lidocaine Treatment in a Pediatric Patient

Authors: Asra Akbar

Journal of Pain & Relief

Volume 6 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

New daily persistent headache (NDPH) is defined as a persistent and daily headache from onset. It is a unique headache that typically seen in people without a prior history of headaches. New daily persistent headache (NDPH) is an often medication-refractory headache disorder, currently classified as a primary headache disorder. Several medications including Onabotulinum toxin injections and sphenopalatine ganglion block are currently under investigation and may provide a potential new effective treatment regimen. IV lidocaine has been used for the management of chronic daily headaches, trigeminal autonomic cephalalgias, neuropathic pain, oro-facial, and postoperative pain. We administered IV lidocaine with successful treatment of headache in a refractory NDPH pediatric patient.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pain & Relief.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pain & Relief
  • SubjectNeuroscience & Neurology
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Asra Akbar”